Entrada Therapeutics Inc.

NASDAQ: TRDA · Real-Time Price · USD
7.99
-0.71 (-8.16%)
At close: May 14, 2025, 3:59 PM
7.97
-0.25%
After-hours: May 14, 2025, 04:20 PM EDT

Entrada Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023
License Revenue 20.2M 139M
License Revenue Growth -85.47% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 10.27M 9.86M 9.97M 9.24M 9.4M 8.65M 7.53M 8.17M 7.94M 9.89M 6.98M 7.33M 6.43M 6.1M 3.85M 3.08M 2.17M 2M 1.27M 1.15M 1.15M
Selling, General, and Administrative Revenue Growth +4.21% -1.12% +7.96% -1.73% +8.63% +14.87% -7.80% +2.91% -19.77% +41.79% -4.85% +14.01% +5.49% +58.35% +24.99% +41.98% +8.66% +56.87% +10.94% 0.00% n/a
Research and Development Revenue 32.07M 32.41M 31.26M 31.14M 27.67M 27.55M 22.19M 26.3M 23.1M 15.69M 18.96M 16.25M 15.72M 12.36M 10.51M 6.83M 6.22M 6.66M 5.7M 4.37M 4.37M
Research and Development Revenue Growth -1.05% +3.70% +0.39% +12.51% +0.43% +24.17% -15.62% +13.84% +47.29% -17.26% +16.68% +3.37% +27.15% +17.59% +53.95% +9.74% -6.51% +16.77% +30.35% 0.00% n/a